Novo Integrated Sciences, Inc. engages in the provision of medical services. The company is headquartered in Bellevue, Washington and currently employs 115 full-time employees. The company went IPO on 2005-07-12. The company operates through two reportable segments: healthcare services and product sales. Its businesses include healthcare, medical technology, manufacturing, research and diagnostics, and products and brands. Its specialized primary health care services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, and others. Its products include Terragenx and ProDip (dietary supplement pouches). Terragenx is a micro-dosing IoNovo Iodine product for all ages and lifestyles. Its medical technologies include telemedicine, and remote patient monitoring.
Follow-Up Questions
Who is the CEO of Novo Integrated Sciences Inc?
Mr. Robert Mattacchione is the Chairman of the Board of Novo Integrated Sciences Inc, joining the firm since 2018.
What is the price performance of NVOS stock?
The current price of NVOS is $0.0005, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Novo Integrated Sciences Inc?
Novo Integrated Sciences Inc belongs to Health Care industry and the sector is Health Care
What is Novo Integrated Sciences Inc market cap?
Novo Integrated Sciences Inc's current market cap is $9865
